Literature DB >> 34919161

Comparison of the diagnostic accuracy and validity of biparametric MRI and multiparametric MRI-based VI-RADS scoring in bladder cancer; is contrast material really necessary in detecting muscle invasion?

Serdar Aslan1, Ismet Mirac Cakir2, Ural Oguz3, Tumay Bekci2, Erhan Demirelli3.   

Abstract

PURPOSE: (1) To evaluate the accuracy and validity of the biparametric MRI (bp-MRI), including T2-weigthed image (WI) and DWI sequences, and the availability of an alternative to the multiparametric MRI (mp-MRI), for the muscle-invasiveness assessment of bladder cancer (BC). (2) To evaluate the diagnostic performance and agreement of readers with different experiences in the abdominal imaging of using both protocols.
METHODS: Preoperative bladder mp-MRI was performed on 128 patients with a initial diagnosis of BC. Two sets of images, set 1 (bp-MRI) and set 2 (mp-MRI), were independently evaluated by both readers. Descriptive statistics, including sensitivity, specificity, accuracy, and area under the curve (AUC), for VI-RADS scores were calculated using ≥ 4 as the cutoff for muscle invasion for each reader and image sets. Inter-reader agreement was evaluated using the Cohen's kappa coefficient.
RESULTS: The sensitivity ranged between 90.3-93.5% and 87.1-90.3%, specificity ranged between 96.6-99.1% and 91.6-96.6%, accuracy ranged between 96-97.3% and 91.3-94.6%, and AUC ranged between 0.947-0.951 and 0.919-0.921, for bp-MRI and mp-MRI, and reader 1 and reader 2, respectively. No significant differences were shown in diagnostic performance for either reader between both the protocols (p = 0.238 and 0.318). There was excellent agreement among the readers in the VI-RADS scores, using both protocols.
CONCLUSION: A bp-MRI protocol has a diagnostic accuracy comparable to an mp-MRI protocol for the detection of muscle-invasive BC using the VI-RADS criteria. Also, in both MRI protocols, the reader's experience does not appear to significantly affect diagnostic performance when using the VI-RADS criteria.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Bladder cancer; Contrast media; Diffusion magnetic resonance imaging; Magnetic resonance imaging; Muscle; Neoplasm invasion

Mesh:

Substances:

Year:  2021        PMID: 34919161     DOI: 10.1007/s00261-021-03383-3

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  25 in total

1.  Value of MRI in local staging of bladder cancer.

Authors:  Mahyar Ghafoori; Madjid Shakiba; Atefeh Ghiasi; Nazanin Asvadi; Kamal Hosseini; Manijeh Alavi
Journal:  Urol J       Date:  2013       Impact factor: 1.510

2.  EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016.

Authors:  Marko Babjuk; Andreas Böhle; Maximilian Burger; Otakar Capoun; Daniel Cohen; Eva M Compérat; Virginia Hernández; Eero Kaasinen; Joan Palou; Morgan Rouprêt; Bas W G van Rhijn; Shahrokh F Shariat; Viktor Soukup; Richard J Sylvester; Richard Zigeuner
Journal:  Eur Urol       Date:  2016-06-17       Impact factor: 20.096

3.  VI-RADS score and tumor contact length in MRI: A potential method for the detection of muscle invasion in bladder cancer.

Authors:  Ahmet Akcay; Ahmet Baki Yagci; Sinan Celen; Yusuf Ozlulerden; Nilay Sen Turk; Furkan Ufuk
Journal:  Clin Imaging       Date:  2021-02-23       Impact factor: 1.605

Review 4.  MRI of Bladder Cancer: Local and Nodal Staging.

Authors:  Iztok Caglic; Valeria Panebianco; Hebert A Vargas; Vlad Bura; Sungmin Woo; Martina Pecoraro; Stefano Cipollari; Evis Sala; Tristan Barrett
Journal:  J Magn Reson Imaging       Date:  2020-02-29       Impact factor: 4.813

Review 5.  An updated critical analysis of the treatment strategy for newly diagnosed high-grade T1 (previously T1G3) bladder cancer.

Authors:  Girish S Kulkarni; Oliver W Hakenberg; Juergen E Gschwend; George Thalmann; Wassim Kassouf; Ashish Kamat; Alexandre Zlotta
Journal:  Eur Urol       Date:  2009-09-01       Impact factor: 20.096

6.  EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines.

Authors:  J Alfred Witjes; Eva Compérat; Nigel C Cowan; Maria De Santis; Georgios Gakis; Thierry Lebret; Maria J Ribal; Antoine G Van der Heijden; Amir Sherif
Journal:  Eur Urol       Date:  2013-12-12       Impact factor: 20.096

7.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

Review 8.  Multiparametric Magnetic Resonance Imaging for Bladder Cancer: Development of VI-RADS (Vesical Imaging-Reporting And Data System).

Authors:  Valeria Panebianco; Yoshifumi Narumi; Ersan Altun; Bernard H Bochner; Jason A Efstathiou; Shaista Hafeez; Robert Huddart; Steve Kennish; Seth Lerner; Rodolfo Montironi; Valdair F Muglia; Georg Salomon; Stephen Thomas; Hebert Alberto Vargas; J Alfred Witjes; Mitsuru Takeuchi; Jelle Barentsz; James W F Catto
Journal:  Eur Urol       Date:  2018-05-10       Impact factor: 20.096

Review 9.  The global burden of urinary bladder cancer: an update.

Authors:  Anke Richters; Katja K H Aben; Lambertus A L M Kiemeney
Journal:  World J Urol       Date:  2019-11-01       Impact factor: 4.226

10.  Bladder cancer: do we need contrast injection for MRI assessment of muscle invasion? A prospective multi-reader VI-RADS approach.

Authors:  Andrea Delli Pizzi; Domenico Mastrodicasa; Michele Marchioni; Giulia Primiceri; Francesca Di Fabio; Roberta Cianci; Barbara Seccia; Barbara Sessa; Erica Mincuzzi; Martina Romanelli; Pietro Castellan; Roberto Castellucci; Antonella Colasante; Luigi Schips; Raffaella Basilico; Massimo Caulo
Journal:  Eur Radiol       Date:  2020-11-19       Impact factor: 7.034

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.